BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05267470-completion@plaintrial.com
DTSTAMP:20261028T220234Z
DTSTART;VALUE=DATE:20240528
SUMMARY:A Study of Bemarituzumab Monotherapy and Combination With Other Ant
 i-cancer Therapy in SqNSCLC With FGFR2b Overexpression (FORTITUDE-201) —
  estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05267470
URL:https://plaintrial.com/trial/NCT05267470
END:VEVENT
END:VCALENDAR